UBS Warburg Upgrades Boston Scientific
Analyst David Lothson says the shares are trading at a sharp discount to Warburg's cardiovascular device index
UBS Warburg upgraded Boston Scientific (BSX )to buy from hold.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like: